Cas:1693-28-3 2-Trifluoromethyl thioxanthone manufacturer & supplier

Chemical Name:2-Trifluoromethyl thioxanthone

CAS.NO:1693-28-3

Synonyms:2-(trifluoromethyl)thioxanthen-9-one;2-(trifluoromethyl)-10H-dibenzo[b,e]thiin-10-one;2-Trifluoromethyl thioxanthone;2-trifluoromethylthioxanthone;9H-Thioxanthen-9-one, 2-(trifluoromethyl)-;MFCD00079785;EINECS 216-893-7;2-(Trifluoromethyl)-9H-thioxanthen-9-one;2-Trifluoromethyl thioxanthone

Molecular Formula:C₁₄H₇F₃OS

Molecular Weight:280.265

HS Code:2932999099

Physical and Chemical Properties:

Melting point:147-151 °C(lit.)

Boiling point:375.1±42.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.602

PSA:45.31000

Exact Mass:280.016968

LogP:4.56

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-(trifluoromethyl)thioxanthen-9-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Trifluoromethyl thioxanthone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(Trifluoromethyl)-9H-thioxanthen-9-one Use and application,9H-Thioxanthen-9-one, 2-(trifluoromethyl)- technical grade,usp/ep/jp grade.

Related News: Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. 2-Trifluoromethyl thioxanthone manufacturer ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment��s chemistry, manufacturing and controls process, but not its safety. 2-Trifluoromethyl thioxanthone supplier ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment��s chemistry, manufacturing and controls process, but not its safety. 2-Trifluoromethyl thioxanthone vendor Inceptua Medicines Access is a business unit of the Inceptua Group. It offers full access solutions for the design, implementation and delivery of Pre-approval and Medicines Access Programs on behalf of biopharmaceutical companies. 2-Trifluoromethyl thioxanthone factory Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.